Emerald Logic

🗓 Founded 2011👥 5 employees💰 Last funded Jun 2012
Biotechnology🌐 emeraldlogic.com
Website LinkedIn
Emerald Logic has created FACET, the world’s only precision analytics platform for integrated multi-omic discovery. The company's mission is to make personalized medicine a reality, thereby eliminating 40% of patient suffering and cutting prescription costs by over $150 billion annually, while helping pharmaceutical companies maintain profits for reinvestment in R&D. Emerald's bio-inspired signal processing technology is proven to solve problems impossible for other methods, by modeling the underlying biology of disease regardless of the number or complexity of available biomarkers, lab assessments, clinical history, and demographics. The company’s body of work includes diagnostics and prognostics for a wide variety of cancers, inflammatory diseases, neurological disorders, cardiac health, and addiction. The company’s customers include major pharma, renowned clinics, and world-class research institutions.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Emerald Logic?
Emerald Logic has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Emerald Logic last raise funding?
The most recent investment in Emerald Logic recorded on gritt.io was in June 2012.
When was Emerald Logic founded?
Emerald Logic was founded in 2011.
What industry is Emerald Logic in?
Emerald Logic operates in Biotechnology. Find similar Biotechnology investors on gritt.io.